January 19, 2017
Pharmacies and pharmacists must redouble their efforts to ensure proper drug distributions after counterfeit versions of the hepatitis C drug Harvoni (ledipasvir + sofosbuvir) were discovered in Japan , the Japan Pharmaceutical Association (JPA) said in a statement on January...read more